BioticsAI Email Format

Software DevelopmentCalifornia, United States11-50 Employees

BioticsAI offers an AI-driven platform that assists obstetric ultrasound by identifying fetal and maternal abnormalities. The system provides autonomous quality assurance and abnormality localization on every screening, aiming to reduce misdiagnosis caused by operator error and to equip clinicians with comprehensive information for pregnancy management. By focusing on ultrasound screenings, the platform seeks to lower the risk of missed or misinterpreted findings that can affect both mother and baby.

Based in San Francisco, the company is a small software development firm operating in the medical imaging space. Its primary users are obstetricians and ultrasound practitioners who perform fetal and maternal screenings, with the goal of improving diagnostic accuracy and consistency. In January 2026, BioticsAI announced FDA clearance for its AI software that helps detect fetal abnormalities from ultrasound images.

Get verified BioticsAI emails free

Company overview Employee directory